CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Lipid modification - primary and secondary CVD prevention - Management
Fibrates - secondary prevention
Age from 18 years onwards
Bezafibrate tablets: 200mg three times a day
Bezafibrate 200mg tablets
Take one tablet three times a day.
Supply 84 tablets.
Bezafibrate m/r tablets: 400mg once a day
Bezafibrate 400mg modified-release tablets
Take one tablet once a day.
Supply 28 tablets.
Fenofibrate micronised m/r tablets (Supralip®): 160mg daily
Fenofibrate micronised 160mg modified-release tablets
Take one tablet once a day.
Supply 28 tablets.
Fenofibrate micronised capsules (Lipantil®): 200mg daily
Fenofibrate micronised 200mg capsules
Take one capsule once a day.
Supply 28 capsules.
Fenofibrate micronised capsules (Lipantil®): 267mg daily
Fenofibrate micronised 267mg capsules
Take one capsule once a day.
Supply 28 capsules.
Ciprofibrate tablets: 100mg once a day
Ciprofibrate 100mg tablets
Take one tablet once a day.
Supply 28 tablets.
Gemfibrozil capsules: 900mg once a day
Gemfibrozil 300mg capsules
Take three capsules daily as a single dose half an hour before the evening meal.
Supply 84 capsules.
Gemfibrozil capsules: 600mg twice a day
Gemfibrozil 600mg tablets
Take one capsule twice a day, half an hour before breakfast and half an hour before the evening meal.
Supply 56 tablets.
© NHS Institute for Innovation and Improvement